期刊
JOURNAL OF IMMUNOLOGY
卷 183, 期 4, 页码 2767-2774出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.0901530
关键词
-
类别
资金
- Spanish Ministry of Science and Innovation [SAF2007-60055, BFU2007-67154]
- Regional Government [CSI09-A08]
Eicosanoids are a broad family of lipids that play a critical role in host defense against bacterial and fungal infections. The first enzyme in the metabolic pathway for the generation of eicosanoids is group IVA phospholipase A(2), also known as cytosolic phospholipase A(2)alpha (cPLA(2)alpha). During phagocytosis, cPLA(2)alpha has been found to translocate to the phagosome, although the molecular mechanism involved in such a translocation has not been elucidated. By using enhanced GFP-tagged proteins we show in this work that a nonphosphorylatable cPLA(2)alpha Mutant (S505A) does not translocate to the phagosomes, but a mutant that mimics phosphorylation on Ser(505) (S505E) does it so readily. During phagocytosis, endogenous cPLA(2)alpha is phosphorylated at Ser(505), and inhibitors of JNK, but not of other related kinases such as p38 or the extracellular-regulated kinases 1 and 2, completely block such a phosphorylation. Inhibition of JNK activity also inhibits the translocation of cPLA(2)alpha to phagosomal membranes, as well as arachidonic acid release to the extracellular medium. Moreover, the S505E mutant makes the enzyme refractory to JNK inhibition, translocating normally to phagosomal membranes. Collectively, these data support a key role for JNK-mediated cPLA(2)alpha phosphorylation at Ser(505) in the sequence of events leading to translocation and activation of the enzyme to phagosomal membranes in human macrophages. The Journal of Immunology, 2009, 183: 2767-2774.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据